Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

119 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Gene transfer of tissue inhibitor of metalloproteinases-3 reverses the inhibitory effects of TNF-alpha on Fas-induced apoptosis in rheumatoid arthritis synovial fibroblasts.
Drynda A, Quax PH, Neumann M, van der Laan WH, Pap G, Drynda S, Meinecke I, Kekow J, Neumann W, Huizinga TW, Naumann M, König W, Pap T. Drynda A, et al. Among authors: kekow j. J Immunol. 2005 May 15;174(10):6524-31. doi: 10.4049/jimmunol.174.10.6524. J Immunol. 2005. PMID: 15879156
Risk of herpes zoster (shingles) in patients with rheumatoid arthritis under biologic, targeted synthetic and conventional synthetic DMARD treatment: data from the German RABBIT register.
Redeker I, Albrecht K, Kekow J, Burmester GR, Braun J, Schäfer M, Zink A, Strangfeld A. Redeker I, et al. Among authors: kekow j. Ann Rheum Dis. 2022 Jan;81(1):41-47. doi: 10.1136/annrheumdis-2021-220651. Epub 2021 Jul 28. Ann Rheum Dis. 2022. PMID: 34321218 Free PMC article.
Rheumatoid pneumoconiosis (Caplan's syndrome).
Schreiber J, Koschel D, Kekow J, Waldburg N, Goette A, Merget R. Schreiber J, et al. Among authors: kekow j. Eur J Intern Med. 2010 Jun;21(3):168-72. doi: 10.1016/j.ejim.2010.02.004. Epub 2010 Mar 2. Eur J Intern Med. 2010. PMID: 20493416 Review.
Canakinumab for Treatment of Adult-Onset Still's Disease to Achieve Reduction of Arthritic Manifestation (CONSIDER): phase II, randomised, double-blind, placebo-controlled, multicentre, investigator-initiated trial.
Kedor C, Listing J, Zernicke J, Weiß A, Behrens F, Blank N, Henes JC, Kekow J, Rubbert-Roth A, Schulze-Koops H, Seipelt E, Specker C, Feist E. Kedor C, et al. Among authors: kekow j. Ann Rheum Dis. 2020 Aug;79(8):1090-1097. doi: 10.1136/annrheumdis-2020-217155. Epub 2020 May 13. Ann Rheum Dis. 2020. PMID: 32404342 Free PMC article. Clinical Trial.
119 results